Gene · 7399
Papers2,630
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 2,630
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The usherin mutation c.2299delG leads to its mislocalization and disrupts interactions with whirlin and VLGR1. | Nat Commun | 2023 | 36810733 | PubTator, text mining | PubMed |
| The prognostic value of tumor mutation burden (TMB) and its relationship with immune infiltration in breast cancer patients. | Eur J Med Res | 2023 | 36805828 | PubTator, text mining | PubMed |
| A novel prognostic model related to oxidative stress for treatment prediction in lung adenocarcinoma. | Front Oncol | 2023 | 36798829 | PubTator, text mining | PubMed |
| USH2A Gene Mutations in Rabbits Lead to Progressive Retinal Degeneration and Hearing Loss. | Transl Vis Sci Technol | 2023 | 36795064 | PubTator, text mining | PubMed |
| Whole genome sequencing for USH2A-associated disease reveals several pathogenic deep-intronic variants that are amenable to splice correction. | HGG Adv | 2023 | 36785559 | PubTator, text mining | PubMed |
| Future Perspectives of Prime Editing for the Treatment of Inherited Retinal Diseases. | Cells | 2023 | 36766782 | PubTator, text mining | PubMed |
| Static Perimetry in the Rate of Progression in USH2A-related Retinal Degeneration (RUSH2A) Study: Assessment Through 2 Years. | Am J Ophthalmol | 2023 | 36764426 | PubTator, text mining | PubMed |
| Ribosome biogenesis factors-from names to functions. | EMBO J | 2023 | 36762427 | PubTator, text mining | PubMed |
| USH2A mutation and specific driver mutation subtypes are associated with clinical efficacy of immune checkpoint inhibitors in lung cancer. | J Zhejiang Univ Sci B | 2023 | 36751700 | PubTator, text mining | PubMed |
| Moving beyond narrow definitions of gene drive: Diverse perspectives and frames enable substantive dialogue among science and humanities teachers in the United States and United Kingdom. | Public Underst Sci | 2023 | 36744384 | PubTator, text mining | PubMed |
| Hereditary etiology of non-syndromic sensorineural hearing loss in the Republic of North Ossetia-Alania. | PeerJ | 2023 | 36743950 | PubTator, text mining | PubMed |
| Significance of logistic regression scoring model based on natural killer cell-mediated cytotoxic pathway in the diagnosis of colon cancer. | Front Immunol | 2023 | 36742322 | PubTator, text mining | PubMed |
| De Novo Mutations Contributes Approximately 7% of Pathogenicity in Inherited Eye Diseases. | Invest Ophthalmol Vis Sci | 2023 | 36729443 | PubTator, text mining | PubMed |
| Mutated axon guidance gene PLXNB2 sustains growth and invasiveness of stem cells isolated from cancers of unknown primary. | EMBO Mol Med | 2023 | 36722641 | PubTator, text mining | PubMed |
| Therapeutic landscape for inherited ocular diseases: Current and emerging therapies. | Singapore Med J | 2023 | 36722513 | PubTator, text mining | PubMed |
| Optimization and Validation of a Virtual Reality Orientation and Mobility Test for Inherited Retinal Degenerations. | Transl Vis Sci Technol | 2023 | 36716040 | PubTator, text mining | PubMed |
| Identification and validation of pyroptosis-related gene landscape in prognosis and immunotherapy of ovarian cancer. | J Ovarian Res | 2023 | 36707884 | PubTator, text mining | PubMed |
| Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor-Positive (HR+)/HER2-Negative Metastatic Breast Cancer. | Clin Cancer Res | 2023 | 36693175 | PubTator, text mining | PubMed |
| SynthEye: Investigating the Impact of Synthetic Data on Artificial Intelligence-assisted Gene Diagnosis of Inherited Retinal Disease. | Ophthalmol Sci | 2023 | 36685715 | PubTator, text mining | PubMed |
| Pseudorabies Virus Mutants Lacking US9 Are Defective in Cytoplasmic Assembly and Sorting of Virus Particles into Axons and Not in Axonal Transport. | Viruses | 2023 | 36680194 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7399/papers?page=23